Literature DB >> 18331180

Infections of electrophysiologic cardiac devices.

Daniel Z Uslan1.   

Abstract

Infections related to electrophysiologic cardiac device placement are increasing dramatically and are associated with adverse outcomes. With the US population aging and living longer, cardiac devices are utilized in an older population with significant comorbidities, making the threat from infectious complications significant. Electrophysiologic cardiac devices typically include an implanted pulse generator and an intravascular lead. Infection may occur at any component of the device, resulting in varied presentations. Bacteremia in cardiac device recipients may reflect primary generator pocket infection, or alternate sources of bacteremia may result in secondary hematogenous lead infection. This review focuses on the pathology, diagnosis, management and prevention of electrophysiologic cardiac device infections.

Entities:  

Mesh:

Year:  2008        PMID: 18331180     DOI: 10.1586/17434440.5.2.183

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  3 in total

1.  Cardiac implantable electronic devices in end-stage renal disease patients: preservation of central venous circulation.

Authors:  Gustavo Lopera; Gerald A Beathard; Jose Exaire; Roger Carrillo
Journal:  J Interv Card Electrophysiol       Date:  2012-06       Impact factor: 1.900

2.  Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients.

Authors:  Jens Brock Johansen; Ole Dan Jørgensen; Mogens Møller; Per Arnsbo; Peter Thomas Mortensen; Jens Cosedis Nielsen
Journal:  Eur Heart J       Date:  2011-01-20       Impact factor: 29.983

3.  The Burden and Risk Factors for Infection of Transvenous Cardiovascular Implantable Electronic Device: a Nationwide Cohort Study.

Authors:  Pil Sung Yang; Jaehan Jeong; So Jeong You; Hee Tae Yu; Tae Hoon Kim; Jung Hoon Sung; Sang Soo Lee; Hyung Deuk Park; Boyoung Joung
Journal:  Korean Circ J       Date:  2019-04-08       Impact factor: 3.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.